| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.091 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |